Cargando…

Clinical trial protocols of repurposed prophylaxis for COVID-19: A review

Efficient therapeutic strategies are needed to counter the COVID-19 pandemic, caused by the SARS-CoV-2 virus. In a context where specific vaccines are not yet available, the containment of the pandemic would be facilitated with efficient prophylaxis. We screened several clinical trials repositories...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sallard, E., Belhadi, D., Lescure, F.-X., Yazdanpanah, Y., Peiffer-Smadja, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532748/ https://www.ncbi.nlm.nih.gov/pubmed/33022293 http://dx.doi.org/10.1016/j.medmal.2020.09.013

Ejemplares similares

Type 1 interferons as a potential treatment against COVID-19
por: Sallard, Erwan, et al.
Publicado: (2020)

Review of trials currently testing treatment and prevention of COVID-19
por: Fragkou, P.C., et al.
Publicado: (2020)

COVID-19 : les thérapeutiques
por: KHERABI, Yousra, et al.
Publicado: (2022)

Corrigendum to “Review of trials currently testing treatment and prevention of COVID-19” [Clin Microbiol Infect 26.8 (2020) 988–998]
por: Fragkou, Paraskevi C., et al.
Publicado: (2021)

Quelles sont les conséquences de l’épidémie COVID-19 sur l’organisation des soins ?
por: Peiffer-Smadja, N., et al.
Publicado: (2020)

Quelles sont les conséquences de l’épidémie COVID-19 sur les personnels de santé ?
por: Cossutta, P., et al.
Publicado: (2020)

Nebulised interferon beta-1a for patients with COVID-19
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study
por: Durand, Claire, et al.
Publicado: (2022)

Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review
por: Andrade, Bruno Silva, et al.
Publicado: (2020)

Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre
por: Peiffer-Smadja, N., et al.
Publicado: (2020)

Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
por: Mohamed, Kawthar, et al.
Publicado: (2021)

COVID-19 vaccines: A race against time
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Vaccins COVID-19 : une course contre la montre
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19
por: Awad, Hoda, et al.
Publicado: (2022)

Jaundice in a patient treated with Anakinra in a context of Covid-19
por: Tarhini, H., et al.
Publicado: (2021)

Mise en place d’un circuit ambulatoire de prise en charge des patients suspects d’infection COVID-19
por: Lehur, A., et al.
Publicado: (2020)

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
por: Ader, Florence, et al.
Publicado: (2022)

Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms
por: Sanghai, Nitesh, et al.
Publicado: (2020)

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
por: Costa, Bárbara, et al.
Publicado: (2021)

Management of pharmacovigilance during the COVID‐19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial
por: Mercier, Noémie, et al.
Publicado: (2023)

Clinical Decision Support Systems for Antibiotic Prescribing: An Inventory of Current French Language Tools
por: Durand, Claire, et al.
Publicado: (2022)

Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis
por: Shiryaev, Sergey A., et al.
Publicado: (2017)

COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development
por: Yim, Joowon, et al.
Publicado: (2021)

Repurposing of antibiotics for clinical management of COVID-19: a narrative review
por: Yacouba, Abdourahamane, et al.
Publicado: (2021)

Émergence de variants E484 K suite à une monothérapie bamlanivimab chez des patients COVID-19 à haut risque d’évolution vers une forme sévère
por: Peiffer-Smadja, N., et al.
Publicado: (2021)

Evaluation of new or repurposed treatments for COVID-19: protocol for the phase Ib/IIa DEFINE trial platform
por: Gaughan, Erin, et al.
Publicado: (2021)

Description des cas possibles de COVID-19 dans un établissement de santé de référence
por: Souhail, B., et al.
Publicado: (2020)

Repurposed drugs for COVID-19: threshold and proof requirements for trials
por: Paul, Mical, et al.
Publicado: (2021)

Repurposing Video Review Infrastructure for Clinical Resuscitation Care in the Age of COVID-19
por: Myers, Sage R., et al.
Publicado: (2021)

Repurposing biomedical informaticians for COVID-19
por: Sosa, Daniel N., et al.
Publicado: (2021)

Repurposed GI Drugs in the Treatment of COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Caractéristiques cliniques et paracliniques de 4 patients confirmés à COVID-19
por: Parisey, M., et al.
Publicado: (2020)

L’hospitalisation en chambre dédiée au risque épidémique et biologique : quels impacts sur les patients et les soignants ? Une approche qualitative
por: Bendjelloul, G., et al.
Publicado: (2020)

COVID-19 Misinformation Prophylaxis: Protocol for a Randomized Trial of a Brief Informational Intervention
por: Agley, Jon, et al.
Publicado: (2020)

Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19
por: Rayner, Craig R., et al.
Publicado: (2020)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings
por: Birgand, Gabriel, et al.
Publicado: (2020)

Caractéristiques sociodémographiques et modes d’exposition chez les patients hospitalisés pour COVID-19 avant et pendant la période de confinement
por: Rahi, M., et al.
Publicado: (2020)

Psychotropic drug repurposing for COVID-19: a systematic review
por: Isayeva, U., et al.
Publicado: (2022)

Hydroxychloroquine for prophylaxis of COVID-19 in health workers: A randomized clinical trial
por: Rojas-Serrano, Jorge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mqaqj2t3j7tlble7mmecmum8io